B3GAT1 and coronary artery disorder: Our findings demonstrate that a simple six-colour flow cytometry panel targeting CD45, CD3, CD4, CD57, CCR7, and CD45RA could provide robust discrimination among healthy donors and patients at different stages of coronary artery disease (iCAD vs. ASCAD).